Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97


Use of a uniform treatment algorithm abolishes racial disparities in glycemic control.

Rhee MK, Ziemer DC, Caudle J, Kolm P, Phillips LS.

Diabetes Educ. 2008 Jul-Aug;34(4):655-63. doi: 10.1177/0145721708320903.


Use of a glucose algorithm to direct diabetes therapy improves A1C outcomes and defines an approach to assess provider behavior.

Miller CD, Ziemer DC, Kolm P, El-Kebbi IM, Cook CB, Gallina DL, Doyle JP, Barnes CS, Phillips LS.

Diabetes Educ. 2006 Jul-Aug;32(4):533-45.


Glycemic control and health disparities in older ethnically diverse underserved adults with diabetes: five-year results from the Informatics for Diabetes Education and Telemedicine (IDEATel) study.

Weinstock RS, Teresi JA, Goland R, Izquierdo R, Palmas W, Eimicke JP, Ebner S, Shea S; IDEATel Consortium.

Diabetes Care. 2011 Feb;34(2):274-9. doi: 10.2337/dc10-1346.


Diabetes care in black and white veterans in the southeastern U.S.

Twombly JG, Long Q, Zhu M, Wilson PW, Narayan KM, Fraser LA, Webber BC, Phillips LS.

Diabetes Care. 2010 May;33(5):958-63. doi: 10.2337/dc09-1556. Epub 2010 Jan 26.


Differences in the Use and Quality of Antidiabetic Therapies in Mexican American and Non-Hispanic Whites With Uncontrolled Type 2 Diabetes in the US: NHANES 2003-2012.

Perez A, Elrod S, Sanchez J.

Diabetes Educ. 2015 Oct;41(5):582-91. doi: 10.1177/0145721715593813. Epub 2015 Jul 14.


Characterization of factors affecting attainment of glycemic control in Asian Americans with diabetes in a culturally specific program.

Le H, Wong S, Iftikar T, Keenan H, King GL, Hsu WC.

Diabetes Educ. 2013 Jul-Aug;39(4):468-77. doi: 10.1177/0145721713492217. Epub 2013 Jun 14.


Medication adherence and racial differences in A1C control.

Adams AS, Trinacty CM, Zhang F, Kleinman K, Grant RW, Meigs JB, Soumerai SB, Ross-Degnan D.

Diabetes Care. 2008 May;31(5):916-21. doi: 10.2337/dc07-1924. Epub 2008 Jan 30.


Revisiting Disparities in Quality of Care Among US Adults With Diabetes in the Era of Individualized Care, NHANES 2007-2010.

Laiteerapong N, Fairchild PC, Chou CH, Chin MH, Huang ES.

Med Care. 2015 Jan;53(1):25-31. doi: 10.1097/MLR.0000000000000255.


Racial disparities in diabetes care processes, outcomes, and treatment intensity.

Heisler M, Smith DM, Hayward RA, Krein SL, Kerr EA.

Med Care. 2003 Nov;41(11):1221-32.


Medication Adherence Does Not Explain Black-White Differences in Cardiometabolic Risk Factor Control among Insured Patients with Diabetes.

Lafata JE, Karter AJ, O'Connor PJ, Morris H, Schmittdiel JA, Ratliff S, Newton KM, Raebel MA, Pathak RD, Thomas A, Butler MG, Reynolds K, Waitzfelder B, Steiner JF.

J Gen Intern Med. 2016 Feb;31(2):188-95. doi: 10.1007/s11606-015-3486-0.


Racial differences in neighborhood disadvantage, inflammation and metabolic control in black and white pediatric type 1 diabetes patients.

Coulon SJ, Velasco-Gonzalez C, Scribner R, Park CL, Gomez R, Vargas A, Stender S, Zabaleta J, Clesi P, Chalew SA, Hempe JM.

Pediatr Diabetes. 2017 Mar;18(2):120-127. doi: 10.1111/pedi.12361. Epub 2016 Jan 18.


Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus.

Menzin J, Korn JR, Cohen J, Lobo F, Zhang B, Friedman M, Neumann PJ.

J Manag Care Pharm. 2010 May;16(4):264-75.


Reducing racial/ethnic disparities in diabetes: the Coached Care (R2D2C2) project.

Kaplan SH, Billimek J, Sorkin DH, Ngo-Metzger Q, Greenfield S.

J Gen Intern Med. 2013 Oct;28(10):1340-9. doi: 10.1007/s11606-013-2452-y.


Racial and ethnic differences in glycemic control of adults with type 2 diabetes.

Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS.

Diabetes Care. 1999 Mar;22(3):403-8.


Racial differences in diabetes self-management and quality of care in Texas.

Nwasuruba C, Osuagwu C, Bae S, Singh KP, Egede LE.

J Diabetes Complications. 2009 Mar-Apr;23(2):112-8. doi: 10.1016/j.jdiacomp.2007.11.005. Epub 2008 Apr 16.


Racial and ethnic differences in mean plasma glucose, hemoglobin A1c, and 1,5-anhydroglucitol in over 2000 patients with type 2 diabetes.

Herman WH, Dungan KM, Wolffenbuttel BH, Buse JB, Fahrbach JL, Jiang H, Martin S.

J Clin Endocrinol Metab. 2009 May;94(5):1689-94. doi: 10.1210/jc.2008-1940. Epub 2009 Mar 10.


Characterization of type 2 diabetes mellitus burden by age and ethnic groups based on a nationwide survey.

Lopez JM, Bailey RA, Rupnow MF, Annunziata K.

Clin Ther. 2014 Apr 1;36(4):494-506. doi: 10.1016/j.clinthera.2013.12.016. Epub 2014 Feb 5.

Supplemental Content

Support Center